PD Dr. Markus Eckstein

Institute of Pathology

Immunotherapy in Genitourinary Cancers: Role of Surgical Pathologist for Detection of Immunooncologic Predictive Factors (2023) Bahlinger V, Hartmann A, Eckstein M Journal article, Review article Transrectal Absorber Guide Raster-Scanning Optoacoustic Mesoscopy for Label-Free In Vivo Assessment of Colitis (2023) Bühler A, Brown E, Paulus LP, Eckstein M, Thoma OM, Oraiopoulou ME, Rother U, et al. Journal article, Original article Rapid single-cell physical phenotyping of mechanically dissociated tissue biopsies (2023) Soteriou D, Kubankova M, Schweitzer C, Lopez Posadas R, Pradhan R, Thoma OM, Györfi AH, et al. Journal article Early C-reactive protein kinetics predicts immunotherapy response in non-small cell lung cancer in the phase III OAK trial (2023) Saal J, Bald T, Eckstein M, Ritter M, Brossart P, Ellinger J, Hoelzel M, Klümper N Journal article The Chorioallantoic Membrane Xenograft Assay as a Reliable Model for Investigating the Biology of Breast Cancer (2023) Ranjan RA, Muenzner JK, Kunze P, Geppert CI, Rübner M, Hübner H, Fasching P, et al. Journal article Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer (2023) Foersch S, Glasner C, Woerl AC, Eckstein M, Wagner DC, Schulz S, Kellers F, et al. Journal article Increasing Biomarker Guidance in the Treatment of Urothelial Carcinoma: Systematic Review of International Clinical Trials (2023) Bolenz C, Kunath F, Zengerling F, Wezel F, Schmidt S, Hartmann A, Eckstein M Journal article, Review article The modified Polsby–Popper score, a novel quantitative histomorphological biomarker and its potential to predict lymph node positivity and cancer-specific survival in oral tongue squamous cell carcinoma (2023) Csűry TD, Csűry AZ, Balk M, Kist A, Rupp R, Müller SK, Sievert M, et al. Journal article Corrigendum to "Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes" [European Urology Oncology (2023)]. (2023) Eckstein M, Matek C, Wagner P, Erber R, Büttner-Herold M, Wild PJ, Taubert H, et al. Journal article, Erratum Gegen Nectin-4 gerichtete Antikörper-Wirkstoff-Konjugate als neue Behandlungsoption für Patienten mit metastasiertem Urothelkarzinom (2023) Klümper N, Eckstein M, Kunath F, Heidegger I, Becker C, Rausch S Journal article